Linkedin Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace Directory

Slide-mounted tissue dissection solution, 2/13:110

AvanSci Bio has expanded its product line for dissecting slide-mounted tissue sections with its 2iD Scope and 2iD Cam for digital annotation of the areas to be dissected and xScision reagents for slide deparaffinization and dissection from paraffinized tissue sections. These new products, along with the company’s existing products for slide-mounted tissue mesodissection, provide a workflow solution capable of replacing manual slide-mounted tissue dissection for most pathology applications.

Horizon, Boehringer team on oncology research, 2/13:109

Horizon Discovery has signed a research service collaboration deal with Boehringer Ingelheim to support Boehringer’s oncology programs by using Horizon’s Discovery toolbox for research projects and profiling compounds at the hit-to-lead, lead optimization, and preclinical stages to elucidate their anticancer properties and help guide drug discovery programs.

CT/NG molecular tests, 2/13:109

Meridian Bioscience has completed beta trials for two new Illumigene molecular amplification tests specifically designed to detect the DNA of Chlamydia trachoma-tis and Neisseria gonorrhoeae, respectively, from swab and urine specimens.

LipoScience, Duke team to ID factors for cardiovascular risk, 2/13:108

LipoScience has entered into a research agreement with Duke University School of Medicine to identify cardiovascular risk factors to be used alone or in combination with other clinical measures to improve stratification and management of acute coronary syndrome. The agreement encompasses studies to be performed with Duke’s CathGen (CatheterizationGenetics) and other patient registries.

Cardiac troponin I test, 2/13:108

Abbott has received CE-marking for its Architect Stat High-Sensitive troponin I assay. The test measures very low levels of cardiac troponin, which allows physicians to evaluate, in two to four hours, whether patients are having a heart attack.

Quality assurance service programs

February 2013—Bio-Rad Laboratories has released three External Quality Assurance Service (EQAS) programs for clinical laboratories and near-patient/point-of-care settings worldwide. They are cardiac markers, ethanol/ammonia, and lipids.

Respiratory sample collection videos, 2/13:108

Copan Diagnostics has worked with infection-control and point-of-care providers to develop training videos and collection guides demonstrating proper technique for collecting respiratory specimens. Among the educational resources Copan has produced are a set of videos for the CDC and Joint Commission to be used in a Web-based course on influenza diagnosis and treatment in ambulatory settings.

MARKETPLACE

TRENDING